# New Animal Drugs; Laidlomycin
> **Food and Drug Administration** · Final rule. · Published 2003-07-18 · Effective 2003-07-18 · 68 FR 42589
## Document
- **Document number:** 03-18162
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 42589
- **CFR reference:** 21 CFR 556
- **Publication date:** 2003-07-18
- **Effective date:** 2003-07-18
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for the establishment of a tolerance for residues of laidlomycin in cattle liver. The previously established acceptable daily intake (ADI) for total residues of laidlomycin is also being codified.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/07/18/03-18162/new-animal-drugs-laidlomycin)
---
*AI Analytics · CC0 1.0*